Great Hill Capital’s Pfizer PFE Stock Holding History

Great Hill Capital’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$303K	Sell	12,572 -2,200	-15%	-$57.5K	0.01%	44
2026 Q1	$415K	Buy	+14,772	New	+$393K	0.03%	46

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Great Hill Capital's PFE Position: Q2 2026 in Review

Great Hill Capital reduced its Pfizer (PFE) stake by 15% in Q2 2026, selling an estimated $57.5K and leaving 12,572 shares worth $303K. The position accounts for 0.01% of the portfolio, ranked #44.

Great Hill Capital first reported a position in PFE in Q1 2026 and has held it in 2 quarters since. The position peaked at $415K in Q1 2026. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Great Hill Capital held 12,572 shares of Pfizer worth $303K as of Q2 2026.
Great Hill Capital sold 2,200 Pfizer shares in Q2 2026, an estimated $57.5K.
Pfizer made up 0.01% of Great Hill Capital's portfolio in Q2 2026, its #44 holding.
Great Hill Capital first reported a position in Pfizer in Q1 2026 and has held it in 2 quarters since.
Great Hill Capital's Pfizer position peaked at $415K in Q1 2026.
2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Great Hill Capital's 13F filing for Q2 2026, filed 27 Jul 2026.